EDSA SCHEDULE 13G: SEC filing
Adage Capital Management, L.P.
Filed with the SEC on · accession 0000919574-26-007577
EDSA filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 12, 2026. Adage Capital Management, L.P. filed a Schedule 13G disclosing beneficial ownership of 1,100,000 common shares of Edesa Biotech, Inc., representing 7.83% of the company. The stock moved -6.3% by the first close after the filing.
Summary of the filing
Adage Capital Management, L.P. filed a Schedule 13G disclosing beneficial ownership of 1,100,000 common shares of Edesa Biotech, Inc., representing 7.83% of the company. The holdings include 550,000 shares issuable upon exercise of warrants.
Key details
How EDSA stock reacted
Close before
$2.22
Nov 11, 2026
First close after
-6.31%
$2.08
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for EDSA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for EDSA?
Click hereFrequently asked questions
What did EDSA file with the SEC on Nov 12, 2026?
EDSA filed a SCHEDULE 13G (SEC filing). Adage Capital Management, L.P. filed a Schedule 13G disclosing beneficial ownership of 1,100,000 common shares of Edesa Biotech, Inc., representing 7.83% of the company. The holdings include 550,000 shares issuable upon exercise of warrants.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did EDSA stock react to this filing?
EDSA closed at $2.22 before the filing and $2.08 on Nov 12, 2026 (-6.31%).
Other EDSA SEC filings
- 8-K · Contract winNov 9, 2026
- SCHEDULE 13G/A · SEC filingNov 4, 2026
- 8-K · SEC filingOct 23, 2026
- 8-K · Fda approvalOct 15, 2026
- SCHEDULE 13G · SEC filingAug 26, 2026
- SCHEDULE 13D/A · SEC filingAug 25, 2026
- SCHEDULE 13D/A · SEC filingAug 25, 2026
- 8-K · Secondary offeringAug 20, 2026
- 424B5 · Secondary offeringAug 20, 2026
- 424B5 · Secondary offeringAug 19, 2026
Get alerts when EDSA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days